Griffiths Richard Ian

10% OwnerSilence Therapeutics plc (SLN) · full profile →Form 4 · filed Feb 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
0 non-derivative · 8 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2025Buy(P)60K9.5M
Feb 13, 2025Buy(P)93K9.4M
Feb 13, 2025Buy(P)60K9.5M
Jan 23, 2025Buy(P)12K9.3M
Jan 21, 2025Buy(P)20K9.3M
Jan 21, 2025Buy(P)25K9.3M
Jan 17, 2025Buy(P)150K9.3M
Jan 8, 2025Buy(P)30K9.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-016802) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about SLN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-25-016802"
Ask your agent
Use Arkolith to summarize insider buying and selling at Silence Therapeutics plc
over the last 90 days and cite the filings.